Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Kidney Transplantation
Interventions
DRUG

Inhaled carbon monoxide

0.7 mg/kg carbon monoxide/placebo over one hour administered 12-48 hours post transplant

DRUG

Inhaled carbon monoxide

2.0 mg/kg carbon monoxide/placebo over one hour administered 12-48 hours post transplant

DRUG

Inhaled carbon monoxide

3.0 mg/kg carbon monoxide/placebo over one hour administered 12-48 hours during transplant

DRUG

Inhaled Carbon Monoxide

3.5 mg/kg carbon monoxide/placebo over one hour administered 12-48 hours during transplant

DRUG

Inhaled Carbon Monoxide

2.0 mg/kg carbon monoxide/placebo over one hour administered 12-48 hours during transplant.

Trial Locations (3)

60611

Northwestern University, Chicago

94143

Universtiy of CA, San Francisco, San Francisco

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY